IL28B Gene Polymorphism SNP rs8099917 Genotype GG Is Associated with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in HTLV-1 Carriers

PLoS Neglected Tropical Diseases

Volumn 8, Issue 9, 2014, Pages

  Assone, Tatiane ^a   Souza, Fernando Vieira de ^b   Gaester, Karen Oliveira ^a   Fonseca, Luiz Augusto Marcondes ^a   Luiz, Olinda do Carmo ^a   Malta, Fernanda ^a   Pinho, João Renato Rebello ^a   Gonçalves, Fernanda de Toledo ^a   Duarte, Alberto Jose da Silva ^a   de Oliveira, Augusto Cesar Penalva ^b   Casseb, Jorge ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Inst de Intectologia Emilio Ribas   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 28; INTERLEUKIN 28B; VIRUS DNA; IL28B PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADULT; ARTICLE; DNA EXTRACTION; FEMALE; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROVIRUS; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TROPICAL SPASTIC PARAPARESIS; VIRUS CARRIER; VIRUS LOAD; AGED; COMPLICATION; GENETICS; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN T-LYMPHOTROPIC VIRUS 1; POLYMERASE CHAIN REACTION; VIROLOGY;

ADULT; AGED; FEMALE; GENOTYPE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROVIRUSES; REAL-TIME POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 84907584290     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003199     Document Type: Article

References (29)

1. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, et al. (1981) Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proceedings of the National Academy of Sciences of the United States of America 78: 6476–6480.
2. Pinheiro SR, Martins-Filho OA, Ribas JG, Catalan-Soares BC, Proietti FA, et al. (2006) Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1. Am J Ophthalmol 142: 811–815.
3. Hoshino H, (2012) Cellular Factors Involved in HTLV-1 Entry and Pathogenicit. Front Microbiol 3: 222.
4. Fujiyoshi T, Li HC, Lou H, Yashiki S, Karino S, et al. (1999) Characteristic distribution of HTLV type I and HTLV type II carriers among native ethnic groups in South America. AIDS Res Hum Retroviruses 15: 1235–1239.
5. Gessain A, Cassar O, (2012) Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol 3: 388.
6. Edlich RF, Arnette JA, Williams FM, (2000) Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). The Journal of emergency medicine 18: 109–119.
7. Moxoto I, Boa-Sorte N, Nunes C, Mota A, Dumas A, et al. (2007) [Sociodemographic, epidemiological and behavioral profile of women infected with HTLV-1 in Salvador, Bahia, an endemic area for HTLV]. Rev Soc Bras Med Trop 40: 37–41.
8. Kamihira S, Usui T, Ichikawa T, Uno N, Morinaga Y, et al. (2012) Paradoxical expression of IL-28B mRNA in peripheral blood in human T-cell leukemia virus type-1 mono-infection and co-infection with hepatitis C virus. Virology journal 9: 40.
9. Trevino A, Lopez M, Vispo E, Aguilera A, Ramos JM, et al. (2012) Development of Tropical Spastic Paraparesis in Human T-Lymphotropic Virus Type 1 Carriers Is Influenced by Interleukin 28B Gene Polymorphisms. Clin Infect Dis 55: e1–e4.
10. Balagopal A, Thomas DL, Thio CL, (2010) IL28B and the control of hepatitis C virus infection. Gastroenterology 139: 1865–1876.
11. Thio CL, Thomas DL, (2010) Interleukin-28b: a key piece of the hepatitis C virus recovery puzzle. Gastroenterology 138: 1240–1243.
12. Dehee A, Cesaire R, Desire N, Lezin A, Bourdonne O, et al. (2002) Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. Journal of virological methods 102: 37–51.
13. Montanheiro PA, Oliveira AC, Posada-Vergara MP, Milagres AC, Tauil C, et al. (2005) Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas/Sociedade Brasileira de Biofisica [et al] 38: 1643–1647.
14. Scherzer TM, Hofer H, Staettermayer AF, Rutter K, Beinhardt S, et al. (2011) Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin. J Hepatol 54: 866–871.
15. Rodriguez S, Gaunt TR, Day IN, (2009) Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. American journal of epidemiology 169: 505–514.
16. Jacobson S, Krichavsky M, Flerlage N, Levin M, (1997) Immunopathogenesis of HTLV-I associated neurologic disease: massive latent HTLV-I infection in bone marrow of HAM/TSP patients. Leukemia 11 Suppl 373–75.
17. Montanheiro P, Vergara MP, Smid J, da Silva Duarte AJ, de Oliveira AC, et al. (2007) High production of RANTES and MIP-1alpha in the tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM). Journal of neuroimmunology 188: 138–142.
18. Sanabani SS, Nukui Y, Pereira J, da Costa AC, de Oliveira AC, et al. (2012) Lack of evidence to support the association of a single IL28B genotype SNP rs12979860 with the HTLV-1 clinical outcomes and proviral load. BMC infectious diseases 12: 374.
19. Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, et al. (2010) Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138: : 1338–1345, 1345 e1331–1337.
20. Martin MP, Qi Y, Goedert JJ, Hussain SK, Kirk GD, et al. (2010) IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. The Journal of infectious diseases 202: 1749–1753.
21. Montanheiro PA, Penalva de Oliveira AC, Smid J, Fukumori LM, Olah I, et al. (2009) The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis. Scand J Immunol 70: 403–407.
22. Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, et al. (1998) Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 4: 586–593.
23. Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, et al. (2000) The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. Journal of immunology 165: 7278–7284.
24. Ge D FJ, Thompson AJ, et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 3.
25. Cavalcante LN, Abe-Sandes K, Angelo AL, Machado TM, Lemaire DC, et al. (2012) IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population. Liver international: official journal of the International Association for the Study of the Liver 32: 476–486.
26. Garcia RF, Moreira S, de Araujo Ramos AL, Ferreira LE, de Mattos AA, et al. (2013) Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection? World journal of gastroenterology: WJG 19: 7399–7404.
27. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, et al. (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nature genetics 41: 1100–1104.
28. Chen L, Sun J, Meng L, Heathcote J, Edwards AM, et al. (2010) ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment. The Journal of general virology 91: 382–388.
29. Jordan WJ, Eskdale J, Srinivas S, Pekarek V, Kelner D, et al. (2007) Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response. Genes and immunity 8: 254–261.